Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7002 USD | +4.35% | -5.25% | -14.79% |
Mar. 18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Camac Partners Provides Information to Shareholders | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.79% | 24.42M | |
-1.40% | 104B | |
+6.83% | 97.47B | |
+5.71% | 22.25B | |
-12.86% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.81% | 16.36B | |
+8.22% | 14.39B | |
+37.55% | 12.37B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Ladenburg Thalmann Downgrades Forte Biosciences to Neutral From Buy